$71.97-1.74 (-2.36%)
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.
RadNet, Inc. in the Healthcare sector is trading at $71.97 with a market capitalization of $5.7B. Wall Street consensus targets $94.62 (8 analysts), implying a +31.5% move over the next 12 months. The stock is currently 16% below its 52-week high of $85.84, remaining 9.0% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $575.63M↑ | $547.71M↑ | $522.87M↑ | $498.23M↑ | $471.40M |
| Gross Profit | $25.12M↓ | $75.93M↑ | $72.49M↑ | $69.14M↑ | $17.92M |
| Operating Income | -$19.85M↓ | $35.08M↑ | $32.69M↓ | $33.15M↑ | -$17.56M |
| Net Income | -$33.47M↓ | -$597,000↓ | $5.42M↓ | $14.45M↑ | -$37.93M |
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance ...

On August 9, RadNet (NASDAQ:RDNT) posted second-quarter revenue of $622.7 million, a 25.0% jump from $498.2 million a year earlier, and raised its full-year outlook for the second time in three months. The imaging network also grew profit at a slower clip than sales, and a six-month net loss widened even as the headline numbers […]

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s what to look for.